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Abstract
Purpose: To investigate the incidence and risk of stroke after percutaneous vertebroplasty in patients with osteoporosis.
Methods: A group of 334 patients with osteoporosis, and who underwent percutaneous vertebroplasty during the study
period, was compared to 1,655 age-, sex- and propensity score-matched patients who did not undergo vertebroplasty. All
demographic covariates and co-morbidities were deliberately matched between the two groups to avoid selection bias.
Every subject was followed-up for up to five years for stroke. Adjustments using a Cox regression model and Kaplan-Meier
analyses were conducted.
Results: A total of 1,989 osteoporotic patients were followed up for 3,760.13 person-years. Overall, the incidence rates of
any stroke, hemorrhagic stroke and ischemic stroke were 22.6, 4.2 and 19.6 per 1,000 person-years, respectively. Patients
who underwent vertebroplasty were not more likely to have any stroke (crude hazard ratio=1.13, p=0.693), hemorrhagic
stroke (HR=2.21, p=0.170), or ischemic stroke (HR=0.96, p=0.90). After adjusting for demographics, co-morbidities and
medications, the vertebroplasty group had no significant difference with the comparison group in terms of any,
hemorrhagic and ischemic strokes (adjusted HR=1.22, 3.17, and 0.96, p=0.518, 0.055, and 0.91, respectively).
Conclusions: Osteoporotic patients who undergo percutaneous vertebroplasty are not at higher risk of any stroke in the
next five years after the procedure.
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Introduction
Stroke is a major cause of disability and death worldwide [1,2].
Osteoporosis, as a known consequence of stroke, causes increased
risk of fractures due to loss of bone desnity and falls [3,4,5,6,7,8,9].
The inter-relationship of stroke, physical inactivity, osteoporosis
and fracture is mutually implicative and constitutes a vicious cycle
for the elderly. An intervention that ameliorates any of these four
components may significantly promote health in this population.
Vertebroplasty is now a common surgical procedure for
osteoporotic vertebral fractures. Aside from being popular among
spine care specialists, its effect of pain relief has been demonstrated
by randomized control studies [10,11,12]. Pulmonary, venous and
cerebrovascular embolism with or without symptoms has been
reported as complications [13,14,15,16]. Moreover, the long-term
effect of vertebroplasty regarding the incidence of stroke in
osteoporotic patients remains elusive.
Although very rare, stroke can happen soon or long after
percutaneous vertebroplasty in osteoporotic patients [13,17,18,19].
There is increased risk of stroke after hip fractures and osteoporotic
vertebral fractures [20]. This study hypothesized that the risk of
stroke in osteoporotic patients did not increase after percutaneous
vertebroplasty.The study also aimed toinvestigate the incidenceand
risk ratios of stroke after percutaneous vertebroplasty, as well as the
differences in specific types (i.e. hemorrhagic or ischemic) of strokes.
In order to investigate such infrequent events and their
correlation with surgery, a large number of patients with an
extremely high follow-up rate was required. Thus, the National
Health Insurance Research Database (NHIRD) was used so that
follow-up would not be affected by patients seeking medical
services across institutions. In Taiwan, hindrance to medical care
is extremely low; this therefore enhanced the completeness and
accuracy of identifying strokes, especially for those that did not
happen immediately post-operation. This cohort study was
deliberately designed to investigate the correlation of percutaneous
vertebroplasty and subsequent strokes by applying a prudently
matched comparison group with very similar disease profiles.
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Data source
The National Health Insurance Research Database (NHIRD) of
Taiwan contains 26 million administered insurants, accumulated
between January 1996 and December 2008. A unique feature of the
database is its comprehensive coverage of 99% of the population
[21], who has unrestricted access to any healthcare provider of the
patient’s choice [22]. NHIRD data are de-identified and encrypted
before their release for medical research. Thus, this study was
exempted from full review by the Institutional Review Board.
The National Health Research Institute (NHRI) recompiles the
medical claims and makes the database publicly available for
research purposes. To protect privacy, individual and hospital
identifiers are unique to the research database and can not be used
to trace back to each individual patient or healthcare provider.
Moreover, regular cross-checks and validation of the medical
charts and claims are performed by the Bureau of National Health
Insurance (NHI) of Taiwan to ensure the accuracy of diagnosis
coding of the NHIRD. Fraudulent coding, overcharging, or
malpractice by physicians and institutions are subject to penalties
or suspension. Therefore, the fidelity of coding in the database is
reliable; this was confirmed by a validation study [23].
Study cohort
This cohort study used a representative cohort composed of one
million of Taiwan’s cumulative population during the period
January 1, 2000 to December 31, 2008. The representative cohort
wasprovidedbythe NHRI througha random selectionforscientific
purposes,with nosignificantdifferencesinage,genderorhealthcare
costs between the representative group and all beneficiaries under
the NHI program. Many studies using this representative cohort
have been published [20,24,25,26]. Extraction of the vertebroplasty
and comparison groups from the database is illustrated in Figure 1.
All original claims data of the extracted subjects were analyzed.
Identification of the vertebroplasty and medical
treatment groups
A total of 58,703 persons with the International Classification of
Disease, 9th Version (ICD-9) diagnostic code for osteoporosis
(733.0) were identified from the database. First-time hospitaliza-
Figure 1. Flow of data processing. From an osteoporotic cohort of 58,703 patients in a nationwide representative cohort of one million people,
421 patients had percutaneous vertebroplasty (vertebroplasty group; n=421), while age-, sex- and propensity score-matched patients comprised the
comparison group (n=1,655). The two groups were compared and followed-up for up to five years for subsequent stroke events.
doi:10.1371/journal.pone.0031405.g001
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plasty (81.65) and percutaneous vertebral augmentation (81.66)
from January 1, 2004 to December 31, 2008 were identified and
enrolled as the vertebroplasty group. The first day of follow-up
(entry date) was defined as the date of vertebroplasty.
A carefully designed one-to-five comparison was conducted.
The osteoporotic cohort also included all enrollees not exposed to
vertebroplasty during the study period. For every subject in the
vertebroplasty group, five subjects who received medical treatment
(but not vertebroplasty) were randomly assigned as the comparison
control group. This group had prudently matched characteristics,
(i.e., propensity scores), as described below.
Propensity scores (i.e., the predicted probability that a person
would receive vertebroplasty) were used to capture the comparison
group in order to adjust for confounding factors associated with
receiving vertebroplasty. The propensity scores were calculated by
medical co-morbidities (i.e., history of hypertension, diabetes,
dyslipidemia, chronic obstructive pulmonary disease, chronic renal
failure, and Parkinson’s disease), demographic characteristics (e.g.,
age, sex, insurance level, geographic location of residence, and
urbanization level of residence), and other spinal diseases (e.g.
spondylosis, spondylolithesis, spinal stenosis, intervertebral disc
disorders, and inflammatory spondylopathies).
The first matched visit date of those in the comparison group
was designated as their first day of follow-up (entry date). Every
subject in the study cohort was tracked back from enrolment
date to January 1, 2000 to ensure no previous vertebroplasty or
stroke events. Each subject was followed-up for up to five years.
The cohort study censored follow-up only on the following
conditions: when the subjects expired, on the dates of outcome
incidence (i.e. stroke), or at the end of this cohort (December 31,
2008) (Fig. 1).
Ascertainment of covariates
There are known and unknown risk factors of stroke [27,28].
This study attempted to include influential covariates of stroke
incidence for adjustment, including co-morbidities, exposure to
medications, and baseline demographic characteristics. Co-
morbidities included: hypertension (ICD-9 code, 401-5.x), diabetes
mellitus (250.x), dyslipidemia (272.0-4), chronic obstructive
pulmonary diseases (COPD) (490, 491.0-1, 491.20-2,491.8-9,
492.0, 492.8, 494, 494.0-1, and 496), chronic renal failure
(585.x), Parkinson disease (332.0), atrial fibrillation (426-7.x),
coronary heart disease (410-4.x), and valvular heart disease (394-
7.x, 424.x). These were determined by the presence of either
diagnostic codes of outpatient records or discharge codes of
hospitalization records six months before the entry dates to the
date of the outcome event or the end of follow-up. Adjustments for
exposure to medications were defined as more than 90 days
cumulative exposure to the medications of aspirin, lipid-lowering
drugs, nitrates, anti-coagulants and non-steroid anti-inflammatory
drugs (NSAIDs) between the entry dates and end of follow-up.
The demographic characteristics of each patient were adjusted
by Charlson’s co-morbidity index, age, sex and socio-economic
status [29,30,31]. Socio-economic status was estimated by
insurance level, and geographic location or residency, and
urbanization level, used a similar method as previous NHIRD
studies [22,32,33]. The income level of each subject was grouped
into one of four categories according to the premium paid (NTD$
$40,000, 20,000–39,999, 1–19,999, and dependents). In the NHI
Table 1. Comparison for demographics and socio-economic status (n=1989).
Comparison group Vertebroplasty group
n=1655 (%) n=334 (%) p value
Gender 0.975
Female 1292 (78.1) 261 (78.1)
Male 363 (21.9) 73 (21.9)
Age, Mean (SD) 75.1 (9.0) 75.0 (9.3) 0.859
Demographic characteristics
Insurance levels (NTD$) 0.427
40,000- 20 (1.2) 2 (.6)
20,000–39,999 625 (37.8) 139 (41.6)
1–19,999 382 (23.1) 69 (20.7)
Dependent 628 (37.9) 124 (37.1)
Geographic locations 0.065
Northern area 712 (43.0) 165 (49.4)
Central area 306 (18.5) 44 (13.2)
Southern area 587 (35.5) 114 (34.1)
Eastern area 50 (3.0) 11 (3.3)
Urbanization levels 0.435
1 (most urbanization) 407 (24.6) 71 (21.3)
2 409 (24.7) 75 (22.5)
3 235 (14.2) 54 (16.2)
4 294 (17.8) 68 (20.4)
5 (least urbanization) 310 (18.7) 66 (19.8)
doi:10.1371/journal.pone.0031405.t001
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and premium rate. Thus, the higher the premium, the implied
higher income. Those without salaries, such as the unemployed,
students, children or the elderly, are designated as dependents by
the Bureau of NHI (BNHI), and the government or their foster
families cover their insurance premiums.
The geographic locations of residency were grouped into four
categories of northern, central, southern and eastern. More economic
and political centers were located in the northern areas. The
urbanization of the locations of NHI registration was also used as a
proxy parameter for socio-economic status. According to previous
reports using the NHIRD [34], urbanization levels are divided into 7
strata, inwhich level 1 is referred to as the ‘‘most urbanized’’ and level
7 as the ‘‘least urbanized’’. However, in our study, given that there
were fewer numbers in levels 5, 6 and 7, these three were combined
into a single group and thereafter referred to as level 5 [31].
Stroke incidences: hemorrhagic vs. ischemic
Any stroke event during the study period, determined by the
date of hospitalization records with the discharge diagnostic code
Table 2. Comparison of co-morbidities (n=1989).
Comparison group Vertebroplasty group
n=1655 (%) n=334 (%) p value
Comorbidities
Hypertension 0.413
Yes 1157 (69.9) 241 (72.2)
No 498 (30.1) 93 (27.8)
Diabetes 0.609
Yes 679 (41.0) 132 (39.5)
No 976 (59.0) 202 (60.5)
Dyslipidemia 0.964
Yes 800 (48.3) 161 (48.2)
No 855 (51.7) 173 (51.8)
COPD 0.288
Yes 874 (52.8) 187 (56.0)
No 781 (47.2) 147 (44.0)
Chronic renal failure 0.659
Yes 141 (8.5) 26 (7.8)
No 1514 (91.5) 308 (92.2)
Parkinson’s disease 0.163
Yes 62 (3.7) 18 (5.4)
No 1593 (96.3) 316 (94.6)
Charlson’s comorbidity index, Mean (SD) 4.01 (2.7) 4.16 (2.8) 0.358
Spinal diseases
Inflammatory spondylopathies 0.991
Yes 10 (.6) 2 (.6)
No 1645 (99.4) 332 (99.4)
Spondylosis 0.747
Yes 224 (13.5) 43 (12.9)
No 1431 (86.5) 291 (87.1)
Spondylolisthesis 0.194
Yes 182 (11.0) 45 (13.5)
No 1473 (89.0) 289 (86.5)
Spinal stenosis 0.009*
Yes 251 (15.2) 70 (21.0)
No 1404 (84.8) 264 (79.0)
Intervertebral disc disorders 0.462
Yes 199 (12.0) 45 (13.5)
No 1456 (88.0) 289 (86.5)
Propensity score, Mean (SD) 0.56 (0.2) 0.58 (0.2) 0.066
*p,0.05.
doi:10.1371/journal.pone.0031405.t002
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identified. The first event of stroke was considered as the outcome
in patients who had more than one stroke. To further analyze the
characteristics of these strokes, all stroke events were further
separated into hemorrhagic strokes, including sub-arachnoid
hemorrhage (ICD- 9 code, 430) and intra-cerebral hemorrhage
(ICD- 9 code, 431–432), and ischemic strokes (ICD- 9 code, 432–
435).
Statistical analysis
All of the data were linked using the SQL server 2008
(Microsoft Corp.) and analyzed by SPSS software (SPSS, Inc.,
Chicago, IL). Chi-square and independent t-tests were used to
compare differences between the vertebroplasty and comparison
groups. The Kaplan-Meier method and log-rank test were used to
estimate the incidence rates of strokes. The Cox proportional
hazard model with propensity scores was used to compare the
stroke incidence rates between the two groups after adjusting for
covariates. A two-tailed level of 0.05 was considered statistically
significant.
Results
A total of 1,989 patients with osteoporosis (i.e. 331 who received
vertebroplasty and 1,655 who did not) were followed-up for
3,760.1 person-years. There were 74 ischemic and 16 hemor-
rhagic stroke events in 85 patients. The overall incidence rates of
any, ischemic and hemorrhagic stroke were 22.6, 4.2 and 19.6 per
1,000 person-years, respectively.
Similar demographics and co-morbidities
The gender distribution (78.1% female), mean age (75 years),
and other parameters of socio-economic status were all very
similar between the vertebroplasty and comparison groups
(Table 1).
The co-morbidities were similar between the two groups,
including hypertension (p=0.413), diabetes (p=0.609), dyslipide-
mia (p=0.964), chronic pulmonary obstructive disease (p=0.288),
chronic renal failure (p=0.659), and Parkinson’s disease
(p=0.163). There were no differences in the Charlson’s co-
morbidity index between the vertebroplasty and comparison
groups (2.8 vs. 2.7, p=0.358). Spinal diseases, including
inflammatory spondylopathies, spondylosis, spondylolisthesis and
intervertebral disc disorders, were also similar except for spinal
stenosis, which was significantly more evident in the vertebroplasty
group (21.0% vs. 15.2%, p=0.009). There were no differences in
the propensity scores between the vertebroplasty and comparison
groups (0.56 vs. 0.58, p=0.066) (Table 2).
Incidence of stroke
There were no significant differences in stroke incidence rates
after vertebroplasty among osteoporosis patients. Among the 334
subjects in the vertebroplasty group, the incidence rates (95%
confidence interval) were 25.9 (15.0–44.6), 7.7 (2.9–20.6) and
19.7 (10.6–36.7) per 1,000 person-years for any stroke, hemor-
rhagic and ischemic strokes, respectively. On the other hand, for
the 1,655 subjects without vertebroplasty in the comparison
group, the incidence rates were 22.1 (17.5–27.8), 3.6 (2.0–6.3)
and 19.6 (15.4–25.1) per 1,000 person-years for any stroke,
hemorrhagic and ischemic strokes, respectively. There were no
statistical differences in stroke incidence rates for stroke sub-types
between the two groups (p=0.585, 0.211, and 0.956, respectively)
(Fig. 2).
The accumulated incidence of each stroke sub-type showed no
significant difference between the vertebroplasty and comparison
groups (Fig. 3).
Figure 2. Comparison of stroke incidence rates. The vertebroplasty group had similar incidence rates of any, hemorrhagic and ischemic strokes
to that of the comparison group.
doi:10.1371/journal.pone.0031405.g002
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Patients in the vertebroplasty group were insignificantly more or
less likely to have stroke compared to the comparison group. The
vertebroplasty group had crude hazard ratios (95% CI) of 1.13
(0.62–2.04), 2.21 (0.71–6.86), and 0.96 (0.49–1.91) for any stroke,
hemorrhagic stroke and ischemic stroke (p=0.693, 0.170, and
0.90, respectively) compared to the comparison group (Table 3).
After adjustments for demographic characteristics, co-morbidities
and medications, the adjusted hazard ratios of the vertebroplasty
group were 1.22 (0.67–2.24), 3.17 (0.97–10.3), and 0.96 (0.49–
1.91) for any stroke, hemorrhagic stroke and ischemic stroke
(p=0.518, 0.055, and 0.91, respectively). Thus, osteoporotic
patients who received vertebroplasty did not have an increased
risk of stroke in the five years post-operation.
Discussion
In the last decade, percutaneous vertebroplasty has been
accepted as an option for spinal compression fractures for elderly
patients with osteoporosis. Numerous reports have demonstrated
its rapid pain relief [10,11,35]. However, in spite of the escalating
number of vertebroplasty procedures performed worldwide, there
is a lack of robust evidence about the long-term effects
[10,11,12,36,37,38]. Stroke is rare after vertebroplasty but can
cause severe neurologic consequences or death [17,18,19]. To
date, the actual incidence and risk of stroke after percutaneous
vertebroplasty remain elusive in the literature.
The current study used a comprehensive nationwide database,
NHIRD, to investigate the risk and incidence of stroke in patients
with osteoporosis, but who were treated differently. A total of 334
vertebroplasty patients and 1,655 medically treated patients were
extracted from an osteoporotic cohort. In a follow-up of five years,
the group of patients who had vertebroplasty was compared to the
well-matched (i.e. age, sex and co-morbidities) group of patients
not treated with vertebroplasty. There were no significant
differences in the incidence and risk of stroke between the two
groups. Thus, percutaneous vertebroplasty does not alter the
chances of stroke in osteoporotic patients. This data also
corroborates the safety of vertebroplasty and long-term medical
outcome.
Several reports of prospective randomized control studies of
vertebroplasty have been published recently [10,11,12]. Most
clinicians agree that in selected patients with acute osteoporotic
vertebral compression fractures and persistent pain, percutaneous
vertebroplasty appears to be an effective and safe procedure. Pain
relief is immediate and sustainable for at least a year, and is
significantly greater than that achieved with conservative treat-
ments [10]. However, the actual long-term outcome of vertebro-
plasty is uncertain. The most common concern of this procedure is
the possible increased risk of vertebral compression fracture at
adjacent spinal levels [39,40]. Other effects of this procedure on
the medical condition of osteoporotic patients who are particularly
old and at a high risk of cardiovascular and other systemic
diseases, are not addressed in the literature. This report is the first
investigation focused on the risk of subsequent stroke after
percutaneous vertebroplasty.
The complication rate of vertebroplasty is low but very serious,
and irreversible complications have been reported, including
spinal cord injury, nerve root compression, venous and pulmonary
embolism, and cardiovascular collapse [13,14,15,16,35,41,42,43].
The elderly, in whom most osteoporotic vertebral compression
fractures occur, are particularly at higher risk of stroke. The
database used in this study is uniquely appropriate to investigate
the risks of stroke after vertebroplasty. Because the monopolistic
government-operated health insurance system offers unlimited
access to health care for the entire population of Taiwan and does
not restrict health service providers, the universal coverage of
health insurance yields an opportunity for an extremely high
follow-up rate. This health insurance system even reimburses
health care services provided by some overseas institutions.
Theoretically, all subsequent stroke events were captured during
the study period. Loss of follow up would only occur if the patient
refused to seek medical attention at all upon having a stroke and
still stayed in the system for a long time, which is very unlikely.
Therefore, the incidence rates computed here are very accurate.
The strength of this report is its demonstration of the rarity and
unlikelihood of stroke after vertebroplasty, even in patients with
osteoporosis, who are older and potentially of a higher risk of
stroke. The well-matched comparative group of patients amelio-
Figure 3. Cumulative incidence of stroke. The vertebroplasty group had similar cumulative incidences of (A) any stroke, (B) hemorrhagic stroke,
and (C) ischemic stroke as the comparison group from the immediate post-operative period till the end of the five-year follow-up.
doi:10.1371/journal.pone.0031405.g003
Table 3. Hazard ratios of subsequent strokes post-vertebroplasty (2004.1.1–2008.12.31, n=1989).
Stroke during 5-year-follow-up Comparison group Vertebroplasty group (95% CI) p value
Any stroke
Crude hazard ratio 1.00 1.13 (0.62–2.04) 0.693
Adjusted hazard ratio
a 1.00 1.22 (0.67–2.24) 0.518
Hemorrhagic stroke
Crude hazard ratio 1.00 2.21 (0.71–6.86) 0.170
Adjusted hazard ratio
a 1.00 3.17 (0.97–10.3) 0.055
Ischemic stroke
Crude hazard ratio 1.00 0.96 (0.49–1.91) 0.90
Adjusted hazard ratio
a 1.00 0.96 (0.49–1.91) 0.91
aAdjustments were made for demographic characteristics (i.e., age, sex, insurance level, geographic location, and urbanization level), co-morbidities (e.g., hypertension,
diabetes, valvular heart disease, arrhythmia, cardiovascular disease and Charlson’s co-morbidity index), medications (e.g., aspirin, nitrates, lipid lowering drugs, anti-
coagulants, and NSAIDs), and baseline propensity scores.
doi:10.1371/journal.pone.0031405.t003
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was specifically aimed at the correlation of vertebroplasty and
stroke. The results indicating the safety of this procedure, although
may be anticipated by most spine surgeons, is proven for the first
time. One can infer that the increased risk of stroke brought on by
osteoporotic spinal compression fracture is likely to be offset by this
procedure. But this inference remains uncertain and its causes also
need further investigation to corroborate.
Furthermore, after the strokes were divided into hemorrhagic
stroke and ischemic stroke, there was still little difference between
the patients who underwent vertebroplasty and others (Fig. 2). The
Kaplan-Meier analysis and adjustment of all other confounding
factors for stroke allowed for a valid estimation of the risks of any,
hemorrhagic and ischemic strokes (Fig. 3). This information may
be valuable in peri-operative management of vertebroplasty for
elderly osteoporotic patients.
This study has several limitations. First, the detailed operative
notes of vertebroplasty were not available for analysis. The levels
of procedure, amount of cement injected, indications of surgery,
and severity of pre-operative symptoms were not analyzed.
Second, the comparison group was composed of osteoporotic
patients with similar medical conditions but not treated by
vertebroplasty; the percentage of acute vertebral compression
fracture in the comparison group may not be as high as those
treated by vertebroplasty. This issue could be a major difference
between the groups (e.g. less severe osteoporosis could imply less
likelihood of stoke). A randomized study of patients with acute
osteoporotic compression fracture may overcome this limitation.
Third, stroke is relatively rare (22.6 per 1,000 person-years) in
these osteoporotic patients. Although the extremely high follow-up
rate substantially compensated for this, a larger scale study with
longer follow-up could further corroborate it.
In conclusion, osteoporotic patients who undergo percutaneous
vertebroplasty are not at higher risk of any stroke in the five years
after the surgery.
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